Phase III clinical study of SUN Y7017 Double blind controlled Study for safety evaluation of 1-step titration with 3-step titration in patients with moderate to severe Alzheimer's disease
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Daiichi Sankyo Company
- 29 Aug 2017 Status changed from active, no longer recruiting to completed.
- 19 Apr 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 27 May 2016 New trial record